The role of immune checkpoint inhibitors: Variable number of tandem repeat (VNTR) polymorphism in the second exon of the P-selectin glycoprotein ligand-1 (PSGL-1) gene polymorphism in multiple myeloma.

MLA

Oyaci, Yasemin, et al. “The Role of Immune Checkpoint Inhibitors: Variable Number of Tandem Repeat (VNTR) Polymorphism in the Second Exon of the P-Selectin Glycoprotein Ligand-1 (PSGL-1) Gene Polymorphism in Multiple Myeloma.” Molecular Carcinogenesis, vol. 63, no. 10, Oct. 2024, pp. 1980–87. EBSCOhost, https://doi.org/10.1002/mc.23787.

APA

Oyaci, Y., Pehlivan, M., Pehlivan, S., Cinli, T. A., Tuncel, F. C., Ertas, E., & Serin, I. (2024). The role of immune checkpoint inhibitors: Variable number of tandem repeat (VNTR) polymorphism in the second exon of the P-selectin glycoprotein ligand-1 (PSGL-1) gene polymorphism in multiple myeloma. Molecular Carcinogenesis, 63(10), 1980–1987. https://doi.org/10.1002/mc.23787

Chicago

Oyaci, Yasemin, Mustafa Pehlivan, Sacide Pehlivan, Tahir Alper Cinli, Fatima Ceren Tuncel, Elif Ertas, and Istemi Serin. 2024. “The Role of Immune Checkpoint Inhibitors: Variable Number of Tandem Repeat (VNTR) Polymorphism in the Second Exon of the P-Selectin Glycoprotein Ligand-1 (PSGL-1) Gene Polymorphism in Multiple Myeloma.” Molecular Carcinogenesis 63 (10): 1980–87. doi:10.1002/mc.23787.